Literature DB >> 2137060

Free radical activity in type 2 diabetes.

A Collier1, R Wilson, H Bradley, J A Thomson, M Small.   

Abstract

Free radical activity has been implicated in the development of diabetic vascular complications in Type 1 diabetes. The aim of the present study was to investigate the levels of free radical scavengers, particularly erythrocyte superoxide dismutase, plasma and erythrocyte lysate thiol, and caeruloplasmin in 22 Type 2 diabetic patients clinically free of complications, and 15 comparable non-diabetic control subjects. The concentration (median (range] of both superoxide dismutase (23 (10-39) vs 45 (25-75) mumol l-1; p less than 0.001) and plasma thiol (374 (172-523) vs 460 (386-595) mumol l-1; p less than 0.01) were reduced in the diabetic group. There were no significant differences in the concentration of erythrocyte lysate thiol (199 (114-520) vs 188 (114-328) mumol l-1) or plasma caeruloplasmin (18 (9-31) vs 24 (6-50) mumol l-1) between the groups. This reduction in superoxide dismutase and the imbalance in the redox status of the plasma and lysate thiol demonstrated is consistent with an increase in free radical activity in Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137060     DOI: 10.1111/j.1464-5491.1990.tb01302.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  28 in total

Review 1.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 2.  Microvascular investigations in diabetes mellitus.

Authors:  S J Chittenden; S K Shami
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

3.  Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.

Authors:  E Dimitriadis; M Griffin; P Collins; A Johnson; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

4.  Oxidative markers in diabetic ketoacidosis.

Authors:  M C Vantyghem; M Balduyck; F Zerimech; A Martin; C Douillard; S Bans; P M Degand; J Lefebvre
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

5.  Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats.

Authors:  S Satyanarayana; J Rajad Sekhar; K Eswar Kumar; L Bacchus Shannika; Bettaiya Rajanna; Sharada Rajanna
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

Review 6.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

7.  Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation.

Authors:  A J Sinclair; A J Girling; L Gray; C Le Guen; J Lunec; A H Barnett
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

8.  Effects of the SOD mimic nitroxide 3-carbamoyl-PROXYL on oxidative stress markers and endothelial dysfunction in streptozotocin-induced diabetic rats.

Authors:  Abdullah Haj-Yehia; Taher Nassar; Bashir Kadery; Chaim Lotan; Nael Da'as; Yosef Kleinman
Journal:  Exp Clin Cardiol       Date:  2002

9.  Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.

Authors:  Makan Golizeh; Kwangwon Lee; Serguei Ilchenko; Abdullah Ösme; James Bena; Rovshan G Sadygov; Sangeeta R Kashyap; Takhar Kasumov
Journal:  Free Radic Biol Med       Date:  2017-10-25       Impact factor: 7.376

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.